All News

Nuclear power is back in favour – but does Europe have the skills and resources to bring the industry into the 21st century?

Thin drug pipelines prompted the biopharmaceuticals licensing splurge of 2006/7. Now pharma and large biotechs are looking to tap into university research too.

The move from the warm embrace of global healthcare giant GE to a tiny biotech start-up was an exhilarating experience for Bill Clarke.

The exchange of knowledge requires professional people who understand how to do it – including how to manage IP, says Gilles Capart from ProTon Europe.

Tough news for America. China’s technological development is set to make it the main driver of world’s economy – and an integrated Europe could overtake it too.

Commissioner Ján Figel has named the people charged with recommending the governing board of the European Institute of Technology.

It’s tough starting a technology business anywhere – but that’s especially true in Central and Eastern Europe…and Trainingpoint’s Ivo Smelhaus talks from bitter experience.